omniture
logo
Search
溪砾科技（深圳）有限公司
Media Room

Latest News

rss

ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders

BRISBANE, Calif., July 26, 2024 /PRNewswire/ -- ReviR Therapeutics, an AI-enabled biotechnology com...

2024-07-26 21:00 3147

CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A

ATLANTA, June 19, 2024 /PRNewswire/ -- The CMT Research Foundation, a non-profit focused solely on ...

2024-06-19 21:00 1772

ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals

BRISBANE, Calif. and SHANGHAI, June 17, 2024 /PRNewswire/ -- ReviR Therapeutics, a biotechnology co...

2024-06-17 22:00 1896

ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Based on ReviR's Comprehensive Approach to RNA-targeted Technologies

SAN FRANCISCO, Feb. 8, 2023 /PRNewswire/ -- ReviR Therapeutics, a privately held developer of a sui...

2023-02-08 22:00 2103

ReviR Therapeutics to Present at RNA Targeted Drug Discovery Summit

SAN FRANCISCO, Calif., Dec. 8, 2022 /PRNewswire/ -- ReviR Therapeutics (ReviR), a biotechnology com...

2022-12-08 23:00 2553

ReviR Therapeutics Expands Research Team by Appointing Dr. Sridhar Narayan as Head of Medicinal Chemistry

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2022 /PRNewswire/ -- ReviR Therapeutics, a biotechnology comp...

2022-10-24 22:00 2566

ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer

SOUTH SAN FRANCISCO, Calif., July 1, 2022  /PRNewswire/ -- ReviR Therapeutics, a biotechnology comp...

2022-07-01 22:00 5102

ReviR Therapeutics Announces Dr. David Dornan as Independent Board Director

SOUTH SAN FRANCISCO, Calif., April 28, 2022 /PRNewswire/ -- ReviR Therapeutics, a biotechnology com...

2022-04-28 22:00 1635